Increasing glucagon secretion could antagonize the action of exogenous insulin for glycemic control in streptozocin-induced diabetic rhesus monkeys

Experimental Biology and Medicine

Volumn 238, Issue 4, 2013, Pages 385-391

  He, Sirong ^a   Wang, Dan ^a   Lu, Yanrong ^a   Chen, Younan ^a   Jin, Xi ^a   Wang, Chengsi ^a   Zhao, Jingming ^a   Ren, Yan ^a   Wang, Li ^b   Li, Hongxia ^b   Cheng, Jingqiu ^a  

^a SICHUAN UNIVERSITY   (China)

^b National Chengdu Center for Safety Evaluation of Traditional Chinese Medicine   (China)

Author keywords

Diabetic rhesus monkeys; Exogenous insulin; Glycemic control; Insulin sensitivity; cells dysfunction

Indexed keywords

ARGININE; INSULIN; TRIACYLGLYCEROL;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FOOD INTAKE; GLUCAGON RELEASE; GLUCONEOGENESIS; GLYCEMIC CONTROL; HISTOLOGY; HYPOGLYCEMIA; INSULIN RESISTANCE; INSULIN SENSITIVITY; LONGITUDINAL STUDY; NONHUMAN; PANCREAS ISLET ALPHA CELL; PHARMACODYNAMICS; RADIOIMMUNOASSAY; RHESUS MONKEY;

EID: 84880470365     PISSN: 15353702     EISSN: 15353699     Source Type: Journal    
DOI: 10.1177/1535370213477974     Document Type: Article

References (26)

1. Jiang G, Zhang BB. Glucagon and regulation of glucose metabolism. Am J Physiol Endocrinol Metab 2003;284:671-8
2. Bansal P, Wang Q. Insulin as a physiological modulator of glucagons secretion. Am J Physiol Endocrinol Metab 2008;295:751-61
3. Ravier MA, Rutter GA, Glucose or Insulin, but not zinc ions, inhibit glucagon secretion from mouse pancreatic α-cells. Diabetes 2005;54:1789-97
4. Brown RJ, Sinaii N, Rother KI. Too much glucagon, too little insulin: time course of pancreatic islet dysfunction in new-onset type 1 diabetes. Diabetes Care 2008;31:1403-4
5. Edgerton DS, Cherrington AD. Glucagon as a critical factor in the pathology of diabetes. Diabetes 2011;60:377-80
6. Guardado-Mendoza R, Davalli AM, Chavez AO, Hubbard GB, Dick EJ, Majluf-Cruz A, Tene-Perez CE, Goldschmidt L, Hart J, Perego C, Comuzzie AG, Tejero ME, Finzi G, Placidi C, La Rosa S, Capella C, Halff G, Gastaldelli A, DeFronzo RA, Folli F. Pancreatic islet amyloidosis, b-cell apoptosis, and a-cell proliferation are determinants of islet remodeling in type-2 diabetic baboons. Proc Natl Acad Sci USA 2009;106:13992-97
7. Kawamori D, Kurpad AJ, Hu J, Liew CW, Shih JL, Ford EL, Herrera PL, Polonsky KS, McGuinness OP, Kulkarni RN. Insulin signaling in α-cells modulates glucagon secretion in vivo. Cell Metab 2009;4:350-61
8. Shah P, Vella A, Basu AS, Schwenk WF, Rizza RA. Lack of suppression of glucagon contributes to postprandial hyperglycaemia in subjects with type 2 diabetes mellitus. J Clin Endocrinol Metab 2000;85:4053-9
9. Clarke WL, Gonder-Frederick LA, Richards FE, Cryer PE. Multifactorial origin of hypoglycemic symptom unawareness in IDDM. Association with defective glucose counterregulation and better glycemic control. Diabetes 1991;40:680-5
10. Muller WA, Faloona GR, Aquilar-Parada E, Unger RH. Abnormal a-cell function in diabetes. N Engl J Med 1970;283:109-15
11. Ahrén B. Glucagon secretion in relation to insulin sensitivity in healthy subjects. Diabetologia 2006;49:117-22
12. Ahrén B. Beta-and alpha-cell dysfunction in subjects developing impaired glucose tolerance: outcome of a 12-year prospective study in postmenopausal Caucasian women. Diabetes 2009;58:726-31
13. Ferrannini E, Muscelli E, Natali A, Gabriel R. Association of fasting glucagon and proinsulin concentrations with insulin resistance. Diabetologia 2007;50:2342-7
14. Laniado S, Segal P, Esrig B. The role of glucagon hypersecretion in the pathogenesis of hyperglycemia following acute myocardial infarction. Circulation 1973;48:797-800
15. Larsson H, Ahrén B. Islet dysfunction in insulin resistance involves impaired insulin secretion and increased glucagon secretion in postmenopausal women with impaired glucose tolerance. Diabetes Care 2000;23:650-7
16. Ishihara H, Maechler P, Gjinovci A, Herrera PL, Wollheim CB. Islet b-cell secretion determines glucagon release from neighbouring α-cells. Nat Cell Biol 2003;4:330-5
17. Hope KM, Tran PO, Zhou H, Oseid E, Leroy E, Robertson RP. Regulation of a-cell function by the b-cell in isolated human and rat islets deprived of glucose: the 'Switch-off' Hypothesis. Diabetes 2004;53: 1488-95
18. Meier JJ, Kjems LL, Veldhuis JD, Lefèbvre P, Butler PC. Postprandial suppression of glucagon secretion depends on intact pulsatile insulin secretion: further evidence for the Intraislet Insulin Hypothesis. Diabetes 2006;55:1051-6
19. Jin X, Zeng L, He S, Chen Y, Tian B, Mai G, Yang G, Wei L, Zhang Y, Li H, Wang L, Qiao C, Cheng J, Lu Y. Comparison of single high-dose streptozotocin with partial pancreatectomy combined with low-dose streptozotocin for diabetes induction in rhesus monkeys. Exp Biol Med 2010;235:877-85
20. Wei L, Lu Y, He S, Jin X, Zeng L, Zhang S, Chen Y, Tian B, Mai G, Yang G, Zhang J, Wang L, Li H, Markmann JF, Cheng J, Deng S. Induction of diabetes with signs of autoimmunity in primates by the injection of multiple-low-dose streptozotocin. Biochem Biophys Res Commun 2011;412:373-8
21. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and b-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985;28:412-9
22. He S, Chen Y, Wei L, Jin X, Zeng L, Ren Y, Zhang J, Wang L, Li H, Lu Y, Cheng J. Treatment and risk factor analysis of hypoglycemia in diabetic rhesus monkeys. Exp Biol Med 2011;236:212-8
23. Brown MS, Goldstein JL. Selective versus total insulin resistance: a pathogenic paradox. Cell Metab 2008;7:125-34
24. Hancock AS, Du A, Liu J, Miller M, May CL. Glucagon deficiency reduces hepatic glucose production and improves glucose tolerance in adult mice. Mol Endocrinol 2010;24:1605-14
25. Lee Y, Wang MY, Du XQ, Charron MJ, Unger RH. Glucagon receptor knockout prevents insulin-deficient type 1 diabetes in mice. Diabetes 2011;60:391-7
26. Ramnanan CJ, Edgerton DS, Kraft G, Cherrington AD. Physiologic action of glucagon on liver glucose metabolism. Diabetes Obes Metab 2011;13(Suppl 1):118-125